| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S | EVP & Head of Research & Product Development | Ordinary Shares | 19,460 | $4,572,905 | $234.99 | 18 Mar 2026 | Direct |
| Ascendis Pharma A/S | EVP & Head of Research & Product Development | Ordinary Shares | 110 | $25,848 | $234.99 | 18 Mar 2026 | By children |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 18 Mar 2026 | 0 | $0 | 3 | EVP & Head of Research & Product Development | 18 Mar 2026, 18:09 |